Suppr超能文献

B4 雄激素阻断:攻击前列腺癌干细胞。

B4 androgen ablation: attacking the prostate cancer stem cell.

机构信息

University of Michigan Comprehensive Cancer Center, 1500 East Medical Center Drive, Room 6302, Ann Arbor, Michigan 48109, USA.

出版信息

J Clin Invest. 2013 Feb;123(2):563-5. doi: 10.1172/JCI67460. Epub 2013 Jan 25.

Abstract

There is increasing evidence that prostate cancers in rodent models and in men contain a cellular subpopulation that displays stem cell properties. These prostate cancer stem cells (PCSCs) lack androgen receptor expression and are increased in castration-resistant disease. In this issue of the JCI, a study from Yoshioka et al. demonstrates that PCSCs are regulated by a pathway in which α6β4 integrin amplifies signaling through ErbB2 and c-Met receptors. Targeting this pathway provides a novel therapeutic strategy for hormone refractory prostate cancer.

摘要

越来越多的证据表明,啮齿动物模型和男性中的前列腺癌中存在具有干细胞特性的细胞亚群。这些前列腺癌干细胞(PCSCs)缺乏雄激素受体表达,并在去势抵抗性疾病中增加。在本期 JCI 中,Yoshioka 等人的研究表明,PCSCs 受 α6β4 整联蛋白调节,该途径通过 ErbB2 和 c-Met 受体放大信号。靶向该途径为激素难治性前列腺癌提供了一种新的治疗策略。

相似文献

1
B4 androgen ablation: attacking the prostate cancer stem cell.B4 雄激素阻断:攻击前列腺癌干细胞。
J Clin Invest. 2013 Feb;123(2):563-5. doi: 10.1172/JCI67460. Epub 2013 Jan 25.
4
New insights into prostate cancer stem cells.前列腺癌干细胞的新见解。
Cell Cycle. 2013 Feb 15;12(4):579-86. doi: 10.4161/cc.23721. Epub 2013 Jan 31.
7
The Efflux Transporter ABCG2 Maintains Prostate Stem Cells.外排转运蛋白ABCG2维持前列腺干细胞。
Mol Cancer Res. 2017 Feb;15(2):128-140. doi: 10.1158/1541-7786.MCR-16-0270-T. Epub 2016 Nov 17.

引用本文的文献

1
Targeting cancer stem cells integrin β4.靶向癌症干细胞整合素β4。
Oncotarget. 2021 Aug 31;12(18):1850-1858. doi: 10.18632/oncotarget.27977.

本文引用的文献

10

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验